DuChemBIO Co.,Ltd. Company Description
DuChemBIO Co.,Ltd. engages in the development, production, and sale of radiopharmaceutical products for cancer diagnosis and treatment in South Korea.
Its products include FP-CIT for diagnosis of Parkinson’s disease and Parkinson's syndrome by measuring the density of dopamine transporters present in the brain striatum; F-DOPA for brain tumor diagnosis with neutralization technology; Neuraceq for diagnosis of Alzheimer's disease by measuring the distribution and density of beta amyloid in the brain; and Vizamyl for early diagnosis of beta amyloid in Alzheimer's disease.
The company also offers FES, a solution for diagnosis of metastatic breast cancer and determination of estrogen receptor status; FACBC for prostate cancer diagnosis; FDG for the diagnosis of tumors; and NaF for the diagnosis of bone-related diseases.
DuChemBIO Co.,Ltd. was founded in 2002 and is based in Seoul, South Korea.
Country | South Korea |
Founded | 2002 |
Industry | Orthopedic, Prosthetic, and Surgical Appliances and Supplies |
Contact Details
Address: 81, Wausan-ro Seoul, 04041 South Korea | |
Phone | 82 2 332 4868 |
Website | duchembio.com |
Stock Details
Ticker Symbol | 176750 |
Exchange | Korea Exchange - KONEX |
Reporting Currency | KRW |
SIC Code | 3842 |